logo

FULC

Fulcrum Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

FULC Filings

2025-11-21 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-19 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-13 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-10-29 · Earnings Call
Fulcrum Therapeutics, Inc. (FULC) Q3 2025 Earnings Call Transcript
2025-10-29 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-29 · Key Events
Form 8-K - Current report
2025-10-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-08-28 · Key Events
Form 8-K - Current report
2025-08-12 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-07-29 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]